Open

Coming up

Don't miss

Replay


LATEST SHOWS

FRANCE IN FOCUS

France: 2014 in review

Read more

#THE 51%

South Africa: Taking a stand against child marriage

Read more

DEBATE

The Future of the Book

Read more

DEBATE

The Future of the Book (part 2)

Read more

REPORTERS

France 24’s best documentaries of 2014

Read more

THE INTERVIEW

'We have to build a new Tunisia', says the president of the Tunisian Parliament

Read more

FACE-OFF

France on alert after attacks: a case of collective hysteria?

Read more

THE INTERVIEW

'Beijing needs to revaluate its policy in the Tibetan areas', says FM of the Tibetan government-in-exile

Read more

INSIDE THE AMERICAS

Uruguay: freed Guantanamo detainees try to adjust to normal life

Read more

Business

GSK to cut 4,000 jobs in Europe and US

Text by News Wires

Latest update : 2010-01-31

Despite rising profits, British pharmaceuticals company GlaxoSmithKline is expected to announce a cut up to 4,000 more jobs. Most of the jobs cut will be in the United States and Europe.

AFP - British pharmaceuticals giant GlaxoSmithKline is to cut up to 4,000 more jobs as it restructures its workforce and focuses increasingly on emerging markets, The Sunday Times reported.
   
The majority of the jobs will be lost in the United States and Europe, the newspaper said.
   
GSK, which employs just under 100,000 staff globally, is expected to reveal plans for the job cuts when it releases its annual results on Thursday, the report said.
   
Its Anglo-Swedish rival AstraZeneca announced on Thursday it plans to axe 8,000 more jobs worldwide by 2014, extending a cost-cutting drive despite soaring profits.
   
While GSK is still seeking to develop new drugs, it is increasingly turning to emerging markets to find growth.
   
This led to it recently cutting 2,000 sales jobs in the United States while adding 1,500 staff in China.
   
The big players in the global pharmaceuticals industry are seeing their profits squeezed as they reduce their reliance on top-selling blockbuster drugs, many of whose patents will soon expire.

Date created : 2010-01-31

  • BENIN

    Chirac joins African leaders in calling for ban on fake drug sales

    Read more

COMMENT(S)